Follow
Steven E. Kahn
Steven E. Kahn
VA Puget Sound Health Care System and University of Washington
Verified email at uw.edu
Title
Cited by
Cited by
Year
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
Diabetes Prevention Program Research Group
New England Journal of Medicine 346 (6), 393-403, 2002
255132002
Mechanisms linking obesity to insulin resistance and type 2 diabetes
SE Kahn, RL Hull, KM Utzschneider
Nature 444 (7121), 840-846, 2006
64942006
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
SE Kahn, SM Haffner, MA Heise, WH Herman, RR Holman, NP Jones, ...
New England Journal of Medicine 355 (23), 2427-2443, 2006
41302006
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
Diabetes Prevention Program Research Group
The Lancet 374 (9702), 1677-1686, 2009
35902009
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
Look AHEAD Research Group
New England Journal of Medicine 369 (2), 145-154, 2013
30642013
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
SE Kahn
Diabetologia 46, 3-19, 2003
28992003
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
SE Kahn, ME Cooper, S Del Prato
The Lancet 383 (9922), 1068-1083, 2014
21942014
The Diabetes Prevention Program (DPP): description of lifestyle intervention
Diabetes Prevention Program Research Group
Diabetes Care 25 (12), 2165-2171, 2002
20492002
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
M Cnop, PJ Havel, KM Utzschneider, DB Carr, MK Sinha, EJ Boyko, ...
Diabetologia 46, 459-469, 2003
20392003
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial
Look AHEAD Research Group
Diabetes Care 30 (6), 1374-1383, 2007
20042007
Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function
SE Kahn, RL Prigeon, DK McCulloch, EJ Boyko, RN Bergman, ...
Diabetes 42 (11), 1663-1672, 1993
19161993
Effect of weight loss with lifestyle intervention on risk of diabetes
RF Hamman, RR Wing, SL Edelstein, JM Lachin, GA Bray, L Delahanty, ...
Diabetes Care 29 (9), 2102-2107, 2006
16502006
Long term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes: four year results of the Look AHEAD trial
Look AHEAD Research Group
Archives of Internal Medicine 170 (17), 1566-1575, 2010
16472010
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
UB Pajvani, M Hawkins, TP Combs, MW Rajala, T Doebber, JP Berger, ...
Journal of Biological Chemistry 279 (13), 12152-12162, 2004
14952004
Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome
DB Carr, KM Utzschneider, RL Hull, K Kodama, BM Retzlaff, JD Brunzell, ...
Diabetes 53 (8), 2087-2094, 2004
14712004
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
SL Masters, A Dunne, SL Subramanian, RL Hull, GM Tannahill, FA Sharp, ...
Nature Immunology 11 (10), 897-904, 2010
14322010
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial
TJ Orchard, M Temprosa, R Goldberg, S Haffner, R Ratner, S Marcovina, ...
Annals of Internal Medicine 142 (8), 611-619, 2005
13012005
Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial
J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ...
JAMA 321 (1), 69-79, 2019
11132019
The role of insulin resistance in nonalcoholic fatty liver disease
KM Utzschneider, SE Kahn
The Journal of Clinical Endocrinology & Metabolism 91 (12), 4753-4761, 2006
10882006
Glucose levels and risk of dementia
PK Crane, R Walker, RA Hubbard, G Li, DM Nathan, H Zheng, S Haneuse, ...
New England Journal of Medicine 369 (6), 540-548, 2013
10792013
The system can't perform the operation now. Try again later.
Articles 1–20